|
Crude odds ratio (95%CI) |
P-value |
Adjusted odds ratio* (95%CI) |
P-value |
Treatments |
|
|
|
|
Non-invasive ventilation |
7.27 (4.41-11.98) |
<0.001 |
3.06
(1.72-5.45) |
<0.001 |
Invasive mechanical ventilation |
5.85 (4.97-6.89) |
<0.001 |
3.99 (3.28-4.86) |
<0.001 |
Blood component transfusion |
5.14 (4.09-6.47) |
<0.001 |
2.70
(2.03-3.59) |
<0.001 |
Renal replacement therapy |
9.94 (8.51-11.61) |
<0.001 |
7.25
(6.07-8.67) |
<0.001 |
Complications and outcomes |
|
|
|
|
Respiratory failure |
5.95 (5.12-6.92) |
<0.001 |
4.08
(3.41-4.89) |
<0.001 |
Circulatory failure |
5.28 (4.32-6.45) |
<0.001 |
2.76
(2.18-3.50) |
<0.001 |
Liver failure |
8.92 (6.09-13.05) |
<0.001 |
6.30 (4.05-9.81) |
<0.001 |
Neurological failure |
3.05 (2.52-3.68) |
<0.001 |
2.05
(1.65-2.55) |
<0.001 |
Hematological failure |
6.04 (4.74-7.69) |
<0.001 |
3.48
(2.63-4.61) |
<0.001 |
In-hospital mortality |
7.24 (5.10-10.28) |
<0.001 |
4.93
(3.15-7.71) |
<0.001 |
Resource utilization |
Coefficient (95% CI) |
P-value |
Adjusted co
efficient* (95% CI)
|
P-value |
Length of hospital stay (days) |
2.9 (2.7-3.0) |
<0.001 |
1.7
(1.6-1.9) |
<0.001 |
Hospitalization cost ($) |
27117 (25469-28765) |
<0.001 |
17013 (15386-18640) |
<0.001 |